The LifeSci Biotechnology Products Index and the LifeSci Biotechnology Clinical Trials Index will be reconstituted as of the market open on Monday, June 18, 2018. All positions will be equally-weighted, with weights determined as of the closing prices on Thursday, June 14, 2018. (There are no changes to the preliminary index changes announced on June 8, 2018.)
LifeSci Biotechnology Clinical Trials Index
Additions (27 stocks):
Deletions (11 stocks):
Summary:
LifeSci Biotechnology Products Index
Additions (4 stocks):
Deletions:
Summary:
The LifeSci Biotechnology Indexes are equal-weighted indexes that track the performance of U.S.-listed biotechnology stocks in two distinct stages in the lifecycle of biotechnology companies – Clinical Trials stage and Product stage. The indexes are calculated with a base value of 1,000 as of June 30, 2004 and have an official inception date of November 3, 2014.
LifeSci Biotechnology Clinical Trials Index – Projected Components as of June 18, 2018
ABEO, ACHN, ADAP, ADRO, ADVM, AGEN, AIMT, AKAO, AKBA, AKCA, ALBO, ALDR, ALNY, ANAB, APLS, ARNA, ARQL, ARRY, ARWR, ASMB, ATNX, ATRA, AVEO, AXON, BCRX, BGNE, BHVN, BLCM, BLUE, BOLD, BPMC, CARA, CBAY, CBIO, CCXI, CLSD, CRBP, CTMX, CYTK, DCPH, DNLI, ECYT, EPZM, ESPR, FATE, FGEN, FOLD, FPRX, GBT, GERN, GLYC, GTHX, IDRA, IMGN, IMMU, INO, INSM, IOVA, ITCI, KPTI, KURA, LJPC, LOXO, MDGL, MGNX, MLNT, MNOV, MRNS, MRTX, MYOK, NVAX, PGNX, PIRS, PRTA, PRTK, PTCT, QURE, RCKT, RCUS, RETA, RGNX, RYTM, SAGE, SELB, SGMO, SGYP, SLDB, SRNE, STML, SYRS, TGTX, TORC, VKTX, VSTM, VYGR, XLRN, XNCR, ZIOP
LifeSci Biotechnology Products Index – Projected Components as of June 18, 2018
ACAD, ACOR, AGIO, ALXN, AMGN, BIIB, BMRN, CELG, CLVS, DOVA, DVAX, ENTA, EXEL, GILD, HALO, ICPT, INCY, IONS, IRWD, KERX, LGND, LXRX, MDCO, MNTA, NBIX, NKTR, OMER, ONCE, PBYI, PTLA, RARE, RDUS, REGN, RIGL, RTRX, SGEN, SRPT, TBPH, TSRO, UTHR, VNDA, VRTX
For more information, visit www.lifesciindex.com